These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 15074596

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of sphingosine synthesis inhibition in transcutaneous delivery of levodopa.
    Gupta BS, Tiwary AK.
    Int J Pharm; 2002 May 15; 238(1-2):43-50. PubMed ID: 11996809
    [Abstract] [Full Text] [Related]

  • 3. Transcutaneous delivery of levodopa: enhancement by fatty acid synthesis inhibition.
    Babita K, Tiwary AK.
    Mol Pharm; 2005 May 15; 2(1):57-63. PubMed ID: 15804178
    [Abstract] [Full Text] [Related]

  • 4. Skin lipid synthesis inhibition: a possible means for enhancing percutaneous delivery of levodopa.
    Babita K, Tiwary AK.
    Curr Drug Deliv; 2004 Oct 15; 1(4):397-403. PubMed ID: 16305401
    [Abstract] [Full Text] [Related]

  • 5. Lipid synthesis inhibitors: effect on epidermal lipid conformational changes and percutaneous permeation of levodopa.
    Babita K, Rana V, Tiwary AK.
    AAPS PharmSciTech; 2005 Oct 24; 6(3):E473-81. PubMed ID: 16354007
    [Abstract] [Full Text] [Related]

  • 6. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
    Bocci G, Barbara C, Vannozzi F, Di Paolo A, Melosi A, Barsanti G, Allegrini G, Falcone A, Del Tacca M, Danesi R.
    Clin Pharmacol Ther; 2006 Oct 24; 80(4):384-95. PubMed ID: 17015056
    [Abstract] [Full Text] [Related]

  • 7. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
    Zheng JL, Liang LJ, Hu WJ, Shen SL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May 24; 28(5):823-7. PubMed ID: 18504211
    [Abstract] [Full Text] [Related]

  • 8. [Influence of the stratum corneum and dermis of the skin on the percutaneous absorption of fluorouracil delivered through skin patch].
    Li GF, Chen JH, Kamiyama F, Yamamoto A, Chen ZL.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep 24; 22(9):800-2. PubMed ID: 12297435
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity.
    Zhao L, Fang L, Xu Y, Zhao Y, He Z.
    Int J Pharm; 2008 Mar 20; 352(1-2):92-103. PubMed ID: 18053661
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Laser treatments on skin enhancing and controlling transdermal delivery of 5-fluorouracil.
    Gómez C, Costela A, García-Moreno I, Llanes F, Teijón JM, Blanco D.
    Lasers Surg Med; 2008 Jan 20; 40(1):6-12. PubMed ID: 18220260
    [Abstract] [Full Text] [Related]

  • 20. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M, Tempero K, Kirby M, Thompson J.
    Clin Ther; 2006 May 20; 28(5):715-24. PubMed ID: 16861093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.